• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于在肿瘤微环境中控制药物释放的基质金属蛋白酶响应性丝球

MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.

作者信息

Kucharczyk Kamil, Florczak Anna, Kaminska Alicja, Guzniczak Natalia, Sikorska Agata, Deptuch Tomasz, Dams-Kozlowska Hanna

机构信息

Department of Cancer Immunology, Poznan University of Medical Sciences, 61-866 Poznan, Poland; Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland.

Department of Cancer Immunology, Poznan University of Medical Sciences, 61-866 Poznan, Poland.

出版信息

Int J Biol Macromol. 2024 Jun;269(Pt 1):132016. doi: 10.1016/j.ijbiomac.2024.132016. Epub 2024 Apr 30.

DOI:10.1016/j.ijbiomac.2024.132016
PMID:38697442
Abstract

Silk is a biocompatible and biodegradable material that enables the formation of various morphological forms, including nanospheres. The functionalization of bioengineered silk makes it possible to produce particles with specific properties. In addition to tumor cells, the tumor microenvironment (TME) includes stromal, immune, endothelial cells, signaling molecules, and the extracellular matrix (ECM). Matrix metalloproteinases (MMPs) are overexpressed in TME. We investigated bioengineered spider silks functionalized with MMP-responsive peptides to obtain targeted drug release from spheres within TME. Soluble silks MS12.2MS1, MS12.9MS1, and MS22.9MS2 and the corresponding silk spheres carrying MMP-2 or MMP-2/9 responsive peptides were produced, loaded with doxorubicin (Dox), and analyzed for their susceptibility to MMP-2/9 digestion. Although all variants of functionalized silks and spheres were specifically degraded by MMP-2/9, the MS22.9MS2 nanospheres showed the highest levels of degradation and release of Dox after enzyme treatment. Moreover, functionalized spheres were degraded in the presence of cancer cells releasing MMP-2/9. In the 2D and 3D spheroid cancer models, the MMP-2/9-responsive substrate was degraded and released from spheres when loaded into MS22.9MS2 particles but not into the control MS2 spheres. The present study demonstrated that a silk-based MMP-responsive delivery system could be used for controlled drug release within the tumor microenvironment.

摘要

丝绸是一种生物相容性和可生物降解的材料,能够形成包括纳米球在内的各种形态形式。生物工程丝绸的功能化使得生产具有特定性质的颗粒成为可能。除了肿瘤细胞外,肿瘤微环境(TME)还包括基质细胞、免疫细胞、内皮细胞、信号分子和细胞外基质(ECM)。基质金属蛋白酶(MMPs)在肿瘤微环境中过度表达。我们研究了用MMP反应肽功能化的生物工程蜘蛛丝,以实现肿瘤微环境内球体的靶向药物释放。制备了可溶性丝MS12.2MS1、MS12.9MS1和MS22.9MS2以及携带MMP-2或MMP-2/9反应肽的相应丝球,装载阿霉素(Dox),并分析它们对MMP-2/9消化的敏感性。尽管功能化丝和球体的所有变体都被MMP-2/9特异性降解,但MS22.9MS2纳米球在酶处理后显示出最高水平的降解和Dox释放。此外,功能化球体在释放MMP-2/9的癌细胞存在下会降解。在二维和三维球体癌症模型中,当装入MS22.9MS2颗粒而非对照MS2球体时,MMP-2/9反应性底物会从球体中降解并释放出来。本研究表明,基于丝绸的MMP反应性递送系统可用于肿瘤微环境内的药物控释。

相似文献

1
MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.用于在肿瘤微环境中控制药物释放的基质金属蛋白酶响应性丝球
Int J Biol Macromol. 2024 Jun;269(Pt 1):132016. doi: 10.1016/j.ijbiomac.2024.132016. Epub 2024 Apr 30.
2
Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells.药物亲和力和靶向递送:丝球体的双重功能化用于将阿霉素递送到 Her2 阳性癌细胞中进行控制释放。
J Nanobiotechnology. 2020 Mar 30;18(1):56. doi: 10.1186/s12951-020-00609-2.
3
Functionalized spider silk spheres as drug carriers for targeted cancer therapy.功能化蜘蛛丝球体作为靶向癌症治疗的药物载体
Biomacromolecules. 2014 Aug 11;15(8):2971-81. doi: 10.1021/bm500591p. Epub 2014 Jul 7.
4
Bioengineering the spider silk sequence to modify its affinity for drugs.对蜘蛛丝序列进行生物工程改造,以改变其对药物的亲和力。
Int J Nanomedicine. 2018 Jul 20;13:4247-4261. doi: 10.2147/IJN.S168081. eCollection 2018.
5
Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins.使用由 MaSp1 和 MaSp2 蛋白衍生的生物工程蛛丝制成的球体来输送化疗药物。
Nanomedicine (Lond). 2018 Feb;13(4):439-454. doi: 10.2217/nnm-2017-0276. Epub 2018 Jan 17.
6
In vivo evaluation of matrix metalloproteinase responsive silk-elastinlike protein polymers for cancer gene therapy.用于癌症基因治疗的基质金属蛋白酶响应性丝-弹性蛋白样蛋白聚合物的体内评估
J Control Release. 2015 Sep 10;213:96-102. doi: 10.1016/j.jconrel.2015.06.022. Epub 2015 Jun 18.
7
Targeted delivery and pH-responsive release of doxorubicin to cancer cells using calcium carbonate/hyaluronate/glutamate mesoporous hollow spheres.采用碳酸钙/透明质酸/谷氨酸介孔中空球靶向递药并响应 pH 值释放阿霉素至癌细胞。
J Colloid Interface Sci. 2017 Sep 15;502:59-66. doi: 10.1016/j.jcis.2017.04.085. Epub 2017 Apr 28.
8
Blending two bioengineered spider silks to develop cancer targeting spheres.将两种生物工程蜘蛛丝混合以开发癌症靶向球体。
J Mater Chem B. 2017 Apr 28;5(16):3000-3011. doi: 10.1039/c7tb00233e. Epub 2017 Apr 5.
9
Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo.功能化丝球在体内能选择性且有效地将细胞毒性药物递送至靶向癌细胞。
J Nanobiotechnology. 2020 Dec 1;18(1):177. doi: 10.1186/s12951-020-00734-y.
10
Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.靶向 Her2 的丝纳米球的细胞摄取、细胞内分布和降解。
Int J Nanomedicine. 2019 Aug 26;14:6855-6865. doi: 10.2147/IJN.S217854. eCollection 2019.

引用本文的文献

1
Developing the Strategy to Use Silk Spheres for Efficient, Targeted Delivery of Oligonucleotide Therapeutics to Cancer Cells.制定使用丝球体将寡核苷酸治疗剂高效、靶向递送至癌细胞的策略。
Int J Nanomedicine. 2025 Jun 23;20:8023-8039. doi: 10.2147/IJN.S519906. eCollection 2025.
2
Multi-Response Au-Nanohybrid Composite Triggered NIR-Light for Effective Anti-Tumor Therapy in Animal Model.多响应金纳米杂化复合材料触发近红外光用于动物模型中的有效抗肿瘤治疗
Int J Nanomedicine. 2025 Jun 5;20:7153-7168. doi: 10.2147/IJN.S519668. eCollection 2025.
3
Delivery of Polypeptide Drugs Using Nanoparticles Made of Recombinant Spider Silks Derived From MaSp4 Protein.
使用源自MaSp4蛋白的重组蜘蛛丝制成的纳米颗粒递送多肽药物。
Int J Nanomedicine. 2025 Mar 3;20:2609-2622. doi: 10.2147/IJN.S510273. eCollection 2025.